0 rating

What’s New in Eczema? An Update on the Current Understanding of the Epidemiology, Pathophysiology, and Clinical Management of Eczema

Emma Wedgeworth, MA, MBBS, MRCP(UK)


Paul TK Chew, FAMS, FRCSEdNational University Health System, SingaporeOphthalmic conditions such as cataract, glaucoma, age-related macular degeneration, corneal opacities, diabetic retinopathy, and trachoma are the leading causes of chronic blindness. According to the World Health Organization, cataract is the most common cause of blindness globally, followed by glaucoma. It is estimated that around 70 million people worldwide currently have a diagnosis of glaucoma and, as the world’s population ages, it is becoming an increasingly important cause of blindness. Moreover, glaucoma can be said to present an even greater public health challenge than cataract, because the blindness it causes is irreversible. In recent years, extensive clinical and basic research has been conducted in the field of ophthalmology with the aim of developing new strategies for treating these ophthalmic diseases. Hence, large amounts of new research data on such subjects as glaucoma, myopia, diabetic retinopathy, cataract surgery, and LASIK are being generated and published. Given the overwhelming amount of information now available on the internet and in journals, keeping up with all of the articles by ophthalmologists and researchers is a challenge. Current Medical Literature – Ophthalmology provides an easy avenue for ophthalmologists and researchers to obtain a comprehensive review of the most important research published on a broad range of topics in the field of ophthalmology, such as ocular adnexae, uvea, external eye disease and cornea, glaucoma, vitreoretinal disease, neuro-ophthalmology and strabismus, and oncology, to name a few. I believe that CML – Ophthalmology provides practical and effective information on the latest developments in a succinct manner, which can be read and assimilated in a short time by all. In addition, dissemination of this knowledge to ophthalmologists and others globally is now even easier, as the latest articles and archived content can be accessed through the website www.currentmedicalliterature.com. The website also allows readers to rate articles, post comments, and complete the reader survey online.I hope you will find CML – Ophthalmology useful in your quest to keep up to date with advances in research in order to provide the best treatments for your patients to help them see better and prevent blindness. Finally, I would like to acknowledge the tremendous efforts and enthusiasm of my colleagues, the editors, who work relentlessly to summarize and review the literature in order to facilitate fascinating but also quick and easy reading.

Return to top


Cellular Phone Dermatitis
Mariko Seishima
CML Dermatology
Atopic Dermatitis: A Review and Evaluation of Treatment with Omalizumab
Lananh T Do, Asif Rafi, and Roger M Katz
CML Dermatology
Current and Future Therapies for Treating Atopic Dermatitis in Pediatric Patients
Mary K Tholman1, Laura J Lester1, and Adelaide A Hebert, MD1,2
Advances in Psoriasis and Inflammatory Skin Diseases
CML Dermatology
Clinical Dermatology
CML Dermatology